Systemic Upregulation of PDGF-B in Patients With Neovascular AMD
Investigative Ophthalmology & Visual Science2013Vol. 55(1), pp. 337–337
Citations Over TimeTop 18% of 2013 papers
Claus Zehetner, Rudolf Kirchmair, Sabrina Neururer, Martina Kralinger, Nikolaos E. Bechrakis, G. Kieselbach
Abstract
Patients with neovascular AMD have significantly higher plasma PDGF-B levels compared with patients with DME and healthy controls. Our study data indicate that PDGF-B may be involved in the pathogenesis of neovascular AMD. (https://eudract.ema.europa.eu number, EudraCT 2010-024654-11)
Related Papers
- [Role of platelet-derived growth factor in the pathogenesis of preeclampsia].(2007)
- Clinical study on the expression of VEGF in serum of preeclampsia pregnancies(2008)
- Effects of serum vascular endothelial growth factor and transforming growth factor-beta 1 on children with henoch-schoenlein purpura(2006)
- Clinical role and expression of platelet-derived growth factor B chain and vascular endothelial growth factor in angioreticuloma(2009)
- → MP55-11 PROGNOSTIC VALUE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), VEGF RECEPTOR 2, PLATELET-DERIVED GROWTH FACTOR-? (PDGF-β), AND PDGF-β RECEPTOR EXPRESSION IN PAPILLARY RENAL CELL CARCINOMA(2017)